NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals
Estimated value
£304.5m
Awarded value
£304.5m
Suppliers
1
Lots
1
Published
06 Apr 2023
Description
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals Offer reference number: CM/PHR/22/5675 CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines - National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Scope
- Reference
- CF-1454500D0O000000rwimUAA
- Total value
- £304,504,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Apr 2023 to 29 Apr 2025
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 12 Dec 2022, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£304.5m
Award date
23 Apr 2023
Contract start
30 Apr 2023
Contract end
29 Apr 2025